GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Cartica Acquisition Corp (OTCPK:CRTAF) » Definitions » Change In Receivables

CRTAF (Cartica Acquisition) Change In Receivables : $0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cartica Acquisition Change In Receivables?

Cartica Acquisition's change in receivables for the quarter that ended in Dec. 2024 was $0.00 Mil. It means Cartica Acquisition's Accounts Receivable stayed the same from Sep. 2024 to Dec. 2024 .

Cartica Acquisition's change in receivables for the fiscal year that ended in Dec. 2024 was $0.00 Mil. It means Cartica Acquisition's Accounts Receivable stayed the same from Dec. 2023 to Dec. 2024 .

Cartica Acquisition's Accounts Receivable for the quarter that ended in Dec. 2024 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Cartica Acquisition's liquidation value for the three months ended in Dec. 2024 was $-14.61 Mil.

Cartica Acquisition Change In Receivables Historical Data

The historical data trend for Cartica Acquisition's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cartica Acquisition Change In Receivables Chart

Cartica Acquisition Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Change In Receivables
- - - -

Cartica Acquisition Quarterly Data
Jan21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cartica Acquisition Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cartica Acquisition  (OTCPK:CRTAF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Cartica Acquisition's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0*91
=

2. In Ben Graham's calculation of liquidation value, Cartica Acquisition's accounts receivable are only considered to be worth 75% of book value:

Cartica Acquisition's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.002-14.615+0.75 * 0+0.5 * 0
=-14.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cartica Acquisition Change In Receivables Related Terms

Thank you for viewing the detailed overview of Cartica Acquisition's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Cartica Acquisition Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Cartica Acquisition Corp (OTCPK:CRTAF) » Definitions » Change In Receivables
Comparable Companies
BHAC TGAAF JVSA NFTN CBRRF ASPC ATEK BLUAF AITR CDAQF AACT ANSC AAM EQV NETD GATE CEP CCIX KFII CCIR
Traded in Other Exchanges
N/A
Address
1345 Avenue of the Americas, c/o Ellenoff Grossman & Schole LLP, New York, NY, USA, 10105
Website
https://www.carticaspac.com
Cartica Acquisition Corp is a blank check company.
Executives
John F Levy director C/O WASHINGTON PRIME GROUP INC., 180 EAST BROAD STREET, COLUMBUS OH 43215
Kishore Kondragunta director 3524 SILVERSIDE ROAD, SUITE 35B, WILMINGTON DE 19810
Suresh Guduru director, 10 percent owner, officer: Chief Executive Officer 3524 SILVERSIDE ROAD, SUITE 35B, WILMINGTON DE 19810
Kyle I. Parent director 3524 SILVERSIDE ROAD, SUITE 35B3524, WILMINGTON DE 19801
Rana Gujral director 3524 SILVERSIDE ROAD, SUITE 35B, WILMINGTON DE 19810
Suresh Singamsetty director 3524 SILVERSIDE ROAD, SUITE 35B, WILMINGTON DE 19810
Asif Ramji director 3399 PEACHTREE ROAD NE, SUITE 1900, ATLANTA GA 30326
Parul Bhandari director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Cartica Acquisition Partners, Llc 10 percent owner 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Steven J. Quamme director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Farida Khambata director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Sanjeev Goel director, officer: Chief Executive Officer 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
C. Brian Coad officer: COO and CFO 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Keki M. Mistry director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Subramanian Ramadorai director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006